Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methohexital vs Propofol for Elective Cardioversion Sedation
NCT04187196Phase 4Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Apr 2020
- Primary completion
- Sep 2022
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 4 trial of methohexital in Atrial fibrillation (AFib), atrial flutter (AFL), sponsored by Wake Forest University Health Sciences. Started Apr 2020; status: completed.
02
Drugs
methohexital
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on NCT04187196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04187196.